Drugbank Logo

Showing drug card for Phenazopyridine (DB01438)

Legend: drug field target field enzyme field

Version 2.5
Creation Date 2007-07-30 16:08:46
Update Date 2009-06-23 18:08:02
Primary Accession Number DB01438
Secondary Accession Number Not Available
Name Phenazopyridine
Drug Type
  • Approved
  • Small Molecule
Description A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity. [PubChem]
Synonyms
  1. PAP
  2. PDP
  3. Pyridacil
Brand Names
  1. Azo-Standard
  2. Baridium
  3. Phenazodine
  4. Phenylazo
  5. Prodium
  6. Pyrazodine
  7. Pyridiate
  8. Pyridium
  9. Sedural
  10. Suladyne
  11. Uristat
  12. Urodine
  13. Urogesic
  14. Viridium
Brand Mixtures Not Available
Chemical IUPAC Name 3-phenyldiazenylpyridine-2,6-diamine
Chemical Formula C11H11N5
Chemical Structure Structure
CAS Registry Number 94-78-0
InChI Identifier InChI=1/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14)/b16-15+/f/h12-13H2
InChI Key QPFYXYFORQJZEC-BKQDAPJRDQ
KEGG Drug Not Available
KEGG Compound C07429 Link Image
PubChem Compound 4756 Link Image
PubChem Substance 9633 Link Image
ChEBI ID Not Available
PharmGKB ID PA450898 Link Image
HET ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] 00271489 Link Image
RxList Link http://www.rxlist.com/cgi/generic/phenazopyridine.htm Link Image
PDRhealth Link http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/pyr1365.shtml Link Image
Wikipedia Link http://en.wikipedia.org/wiki/Phenazopyridine Link Image
FDA Label Not Available
Material Safety Data Sheet (MSDS)
Synthesis Reference Not Available
Average Molecular Weight 213.2385
Monoisotopic Molecular Weight 213.1014
State Solid
Melting Point 139 oC
Experimental Water Solubility Not Available Source: PhysProp
Predicted Water Solubility 2.02e-01 mg/mL Calculated using ALOGPS
Experimental LogP/Hydrophobicity Not Available Source: PhysProp
Predicted LogP 2.31 Calculated using ALOGPS
Experimental LogS Not Available
Predicted LogS -3.02 Calculated using ALOGPS
Experimental Caco2 Permeability Not Available
pKa/Isoelectric Point Not Available
Mass Spectrum Not Available
MOL File Show Link Image | Download Link Image
SDF File Show Link Image | Download Link Image
PDB File Show Link Image | Download Link Image
2D Structure
3D Structure
Experimental PDB ID Not Available
Isomeric SMILES NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1
Canonical SMILES NC1=NC(N)=C(C=C1)N=NC1=CC=CC=C1
Drug Category
  • Anesthetics, Local
ATC Codes
AHFS Codes
  • 84:08.00
Indication For the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.
Pharmacology Phenazopyridine is a local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
Mechanism of Action Phenazopyridine's mechanism of action is not well known, and only basic information on its interaction with the body is available. It is known that the chemical has a direct topical analgesic effect on the mucosa lining of the urinary tract.
Absorption Not Available
Toxicity Methemoglobinemia generally follows a massive, acute overdose.
Protein Binding Not Available
Biotransformation Likely hepatic but also in other tissues. One of the metabolites is acetaminophen.
Half Life Not Available
Dosage Forms
Form Route
Tablet Oral
Tablet Oral
Patient Information Show Link Image
Contraindications Show Link Image
Interactions Not Available
Drug Interactions Not Available
Food Interactions
  • Take with food to reduce irritation.
Pathways Not Available
General References
  1. Wikipedia Link Image
  2. RxList Link Image
  3. PDRhealth Link Image
Organisms Affected
  • Humans and other mammals

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.